Australia's most trusted
source of pharma news
Monday, 16 September 2024
Posted 9 August 2024 AM
Change is sweeping through Communications teams in Australian pharma, with top level promotions leaving a string of plum jobs up for grabs.
At Johnson & Johnson Innovative Medicine Adam Wyldeck has left his Sydney-based role as Head of Communications to join the company's thriving US Oncology business, leading Communications and Public Affairs. No word on his replacement - though the role has been advertised externally and the recruitment process is ongoing.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.